Repair or progression after AKI: A role for biomarkers?

Nephron - Clinical Practice

Volumn 127, Issue 1-4, 2014, Pages 185-189

  Srisawat, Nattachai ^a,b   Murugan, Raghavan ^b   Kellum, John A ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Biomarkers; Renal recovery

Indexed keywords

BIOLOGICAL MARKER; CREATININE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; EPIDERMAL GROWTH FACTOR; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SCATTER FACTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ACUTE PHASE PROTEIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; INTERLEUKIN DERIVATIVE; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ACUTE KIDNEY FAILURE; CELL COMMUNICATION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CONFERENCE PAPER; CONVALESCENCE; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DISEASE COURSE; DISEASE SEVERITY; HUMAN; KIDNEY BLOOD FLOW; KIDNEY TUBULE CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; URINE VOLUME; ACUTE KIDNEY INJURY; BLOOD; COHORT ANALYSIS; DIURESIS; EPITHELIUM CELL; KIDNEY; KIDNEY PROXIMAL TUBULE; MULTICENTER STUDY (TOPIC); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; COHORT STUDIES; DISEASE PROGRESSION; DIURESIS; EPITHELIAL CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERLEUKINS; KIDNEY; KIDNEY TUBULES, PROXIMAL; LIPOCALINS; MULTICENTER STUDIES AS TOPIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOVERY OF FUNCTION; REGENERATION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84927712291     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000363254     Document Type: Conference Paper

References (37)

1. VA/NIH Acute Renal Failure Trial Network, Palevsky PM, et al: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
2. RENAL Replacement Therapy Study Investigators, Bellomo R, et al: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638.
3. Bellomo R, et al; Acute Dialysis Quality Initiative workgroup: Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
4. Shibe S, Cantley LG: Epithelial-mesenchymal-epithelial cycling in kidney repair. Curr Opin Nephrol Hypertens 2008; 17: 379-385.
5. Liu KD, Brakeman PR: Renal repair and recovery. Crit Care Med 2008; 36:S187-S192.
6. Singbartl K, Kellum JA: AKI in the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81: 819-825.
7. Sirin Y, Susztak K: Notch in the kidney: development and disease. J Pathol 2012; 226: 394-403.
8. McCright B: Notch signaling in kidney development. Curr Opin Nephrol Hypertens 2003; 12: 5-10.
9. Kobayashi T, et al: Expression and function of the Delta-1/Notch-2/Hes-1 pathway during experimental acute kidney injury. Kidney Int 2008; 73: 1240-1250.
10. Gupta S, et al: Effect of Notch activation on the regenerative response to acute renal failure. Am J Physiol Renal Physiol 2010; 298: F209-F215.
11. Bielesz B, et al: Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120: 4040-4054.
12. Yang L, et al: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 2010; 16: 535-543.
13. Cianciolo C, et al: Histone deacetylase inhibitor enhances recovery after AKI. J Am Soc Nephrol 2013; 24: 943-953.
14. Zhou L, et al: Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 2010; 21: 31-41.
15. Bhandari S, Turney JH: Survivors of acute renal failure who do not recover renal function. QJM 1996; 89: 415-421.
16. Uchino S, et al, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005; 294: 813-818.
17. Bell M, et al: Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33: 773-780.
18. Uchino S, et al: Continuous renal replacement therapy: a worldwide practice survey-the beginning and ending supportive therapy for the kidney (BEST kidney) investigators. Intensive Care Med 2007; 33: 1563-1570.
19. Lo LJ, et al: Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009; 76: 893-899.
20. Choi AI, et al: Long-term clinical consequences of acute kidney injury in the HIVinfected. Kidney Int 2010; 78: 478-485.
21. Newsome BB, et al: Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Intern Med 2008; 168: 609-616.
22. James MT, et al: Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int 2010; 78: 803-809.
23. James MT, et al; Alberta Kidney Disease Network: Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010; 376: 2096-2103.
24. Wald R, et al; University of Toronto Acute Kidney Injury Research Group: Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009; 302: 1179-1185.
25. Lafrance JP, et al: Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant 2010; 25: 2203-2209.
26. Ishani A, et al: Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009; 20: 223-228.
27. Ishani A, et al: The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 2011; 171: 226-233.
28. Amdur RL, et al: Outcomes following diagnosis of acute renal failure in US veterans: focus on acute tubular necrosis. Kidney Int 2009; 76: 1089-1097.
29. Uchino S, et al: External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med 2005; 33: 1961-1967.
30. Macedo E, et al: Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011; 80: 760-767.
31. Uchino S, et al: Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med 2009; 37: 2576-2582.
32. Srisawat N, et al; Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Investigators: Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int 2011; 80: 545-552.
33. Srisawat N, et al: Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin J Am Soc Nephrol 2011; 6: 1815-1823.
34. Murugan R, et al: Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol Dial Transplant 2014, DOI: 10.1093/ ndt/gfu051.
35. Kashani K, et al: Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013; 17:R25.
36. Bihorac A, et al: Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014; 189: 932-939.
37. Srisawat N, et al: Recovery from acute kidney injury: determinants and predictors. Contrib Nephrol 2010; 165:284-291.